Concepedia

Publication | Closed Access

Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial

DOI

131

Citations

28

References

2014

Year

Ravi Retnakaran, Caroline K. Kramer, Haysook Choi, Balakumar Swaminathan, Bernard Zinman
Diabetes Care

Abstract

Liraglutide provides robust enhancement of β-cell function that is sustained over 48 weeks in early T2DM but lost upon cessation of therapy.

References

YearCitations

Page 1